ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,198Medicare Part D Prescriptions Filled, Including Refills

Rank: 86 out of 1000

$948K Total Retail Price of All Prescriptions

Rank: 59 out of 1000

1,057 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
53% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 1,057 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

21% of this provider’s 1,057 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

2% of this provider’s 13,315 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 1,143 669 S3 1 1
SIMVASTATIN 777 666 2 3
OMEPRAZOLE 558 459 3 2
LISINOPRIL 550 409 4 5
LEVOTHYROXINE SODIUM 504 422 5 4
METFORMIN HCL 380 276 6 8
AMLODIPINE BESYLATE 370 289 7 6
ZOLPIDEM TARTRATE 355 168 8 16
ATORVASTATIN CALCIUM 346 230 9 18
MELOXICAM 295 250 10 14
PRAVASTATIN SODIUM 291 204 11 12
CARVEDILOL 285 216 12 15
FUROSEMIDE 281 231 13 7
SERTRALINE HCL 279 243 14 26
LISINOPRIL-HYDROCHLOROTHIAZIDE 275 215 15 20
METOPROLOL SUCCINATE 273 268 16 21
GABAPENTIN 254 177 17 11
POTASSIUM CHLORIDE 222 180 18 10
METOPROLOL TARTRATE 210 179 19 19
LOVASTATIN 194 172 20 41
TAMSULOSIN HCL 191 159 21 33
TRAMADOL HCL 191 126 21 13
HYDROCHLOROTHIAZIDE 170 135 23 9
WARFARIN SODIUM 164 134 24 22
CLOPIDOGREL 156 129 25 35
AZITHROMYCIN 152 111 26 36
ALLOPURINOL 150 136 27 31
CELEBREX 149 97 28 98
LOSARTAN-HYDROCHLOROTHIAZIDE 147 119 29 38
CRESTOR 138 99 30 30
LYRICA 136 63 31 47
BENAZEPRIL HCL 133 108 32 61
NEXIUM 131 81 33 23
CITALOPRAM HBR 122 56 34 17
CIPROFLOXACIN HCL 122 100 34 46
LOSARTAN POTASSIUM 121 81 36 25
DONEPEZIL HCL 119 112 37 32
ATENOLOL 117 71 38 24
RANITIDINE HCL 117 102 38 37
GLIMEPIRIDE 113 98 40 34
PANTOPRAZOLE SODIUM 112 62 41 28
FENOFIBRATE 109 74 42 55
CLONIDINE HCL 109 58 42 27
PAROXETINE HCL 98 51 44 63
PLAVIX 91 77 45 49
LEVOFLOXACIN 91 67 45 73
CYCLOBENZAPRINE HCL 88 32 R 47 39
METFORMIN HCL ER 88 66 47 44
GLYBURIDE-METFORMIN HCL 84 82 R 49 121
SULFAMETHOXAZOLE-TRIMETHOPRIM 84 56 49 70
AMOXICILLIN 83 77 51 89
ADVAIR DISKUS 82 54 52 65
TRAZODONE HCL 81 23 53 29
ROPINIROLE HCL 81 49 53 82
AMLODIPINE BESYLATE-BENAZEPRIL 81 72 53 59
CYMBALTA 77 43 56 53
VENLAFAXINE HCL ER 76 56 57 124
FLUTICASONE PROPIONATE 75 52 58 40
AMITRIPTYLINE HCL 74 52 R 59 45
ENALAPRIL MALEATE 72 53 60 58
MECLIZINE HCL 69 61 61 80
HUMULIN 70-30 68 61 62 131
HYDRALAZINE HCL 68 61 62 74
GLYBURIDE 67 60 R 64 92
DOXYCYCLINE HYCLATE 66 40 65 97
FOSINOPRIL SODIUM 65 60 66 154
NAMENDA 64 64 67 43
FLUOXETINE HCL 62 27 68 51
TRIAMTERENE-HCTZ 61 58 69 48
AMOX TR-POTASSIUM CLAVULANATE 60 41 70 125
LANTUS SOLOSTAR 59 35 71 120
LIPITOR 58 38 72 170
DIOVAN HCT 58 49 72 96
JANUVIA 56 56 74 85
SINGULAIR 56 27 74 84
DIGOXIN 56 54 74 52
VENTOLIN HFA 54 21 77 83
TRIAMTERENE-HYDROCHLOROTHIAZID 50 27 78 194
PROAIR HFA 50 26 78 50
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 22, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.